Linked Data API

Show Search Form

Search Results

1131746
unstar this property registered interest false more like this
unstar this property date less than 2019-06-12more like thismore than 2019-06-12
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
unstar this property hansard heading National Institute for Health and Care Excellence more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what opportunities there will be for patient groups that are not part of the NICE Methods Working Group to take part in the task and finish groups. more like this
star this property tabling member constituency Cambridge more like this
star this property tabling member printed
Daniel Zeichner more like this
star this property uin 263874 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove filter
star this property answer text <p>The National Institute for Health and Care Excellence (NICE) is an independent body and is responsible for the methods and processes used in the development of its technology appraisal and highly specialised technologies recommendations. NICE has now initiated the review of its technology appraisal and highly specialised technologies methods in line with the commitment made in the 2019 Voluntary Scheme for Branded Medicines Pricing and Access.</p><p> </p><p>The Voluntary Scheme states that industry and other relevant stakeholders will be active participants in the review, including inputting on scope, participating in working discussions, and providing views on recommendations. NICE’s updated methods guide will also be subject to a public consultation.</p><p> </p><p>NICE has established a working group, consisting of members from NICE, NHS England, the Department, patient organisations and the life sciences industry. The working group reports to a steering group, chaired by NICE and with members from NHS England, the Department, and an independent academic methodologist. The steering group will present its recommendations to NICE’s Senior Management Team, which in turn will report to the NICE Board. NICE approached patient groups with experience of NICE and its processes and methods. There are three patient group representatives on the working group with a wide range of experience, covering a range of topic areas, reflecting the programmes under review. Membership of the working group will be published in due course.</p><p> </p><p>NICE is now in the process of scoping the review of the methods for technology appraisal and highly specialised technologies evaluations with input from the working group and steering group. The scope of the review - a list of the aspects of NICE’s current methods that will be considered in the review - will be presented to the NICE Board in July. Additional detail and more information will be made available on the NICE website in due course. NICE anticipates being in a position to confirm the revised methods guide by the end of 2020, following public consultation.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property grouped question UIN
263870 more like this
263871 more like this
263872 more like this
263873 more like this
star this property question first answered
less than 2019-06-20T13:18:08.323Zmore like thismore than 2019-06-20T13:18:08.323Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4382
unstar this property label Biography information for Daniel Zeichner more like this
1131830
unstar this property registered interest false more like this
unstar this property date less than 2019-06-12more like thismore than 2019-06-12
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
unstar this property hansard heading Infectious Diseases: Fungi more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the risks to patient health posed by fungal infections; and what steps he is taking to tackle those risks. more like this
star this property tabling member constituency Warley more like this
star this property tabling member printed
John Spellar more like this
star this property uin 263692 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove filter
star this property answer text <p>The most common invasive fungal infection in the United Kingdom is blood stream infection with yeast, often following surgical interventions. Public Health England (PHE) has prepared advisory documentation for national dissemination and individual hospital response following recent outbreaks caused by this organism, which can be viewed at the following link:</p><p><a href="https://www.gov.uk/government/publications/candida-auris-emergence-in-england/candida-auris-within-the-united-kingdom-updated-guidance-published" target="_blank">https://www.gov.uk/government/publications/candida-auris-emergence-in-england/candida-auris-within-the-united-kingdom-updated-guidance-published</a></p><p>Invasive mould infections such as invasive aspergillosis are more often seen in patients with haematological malignancies or those undergoing treatment for them, and it is difficult to capture absolute data on the incidence of these due to difficulty in definitive diagnosis.</p><p>Chronic yeast infections are frequently seen in females that have suffered recurrent bouts of vaginal candidosis (thrush). Estimates suggest that 70% of women report having had at least one episode whilst 8% have repeated and persistent infections. Dermatophyte infections, including athletes’ foot are extremely common, found in about 10% of the adult population at any one time. Scalp and nail infections with these organisms are more disfiguring and difficult to treat.</p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property question first answered
less than 2019-06-20T15:39:41.017Zmore like thismore than 2019-06-20T15:39:41.017Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
318
unstar this property label Biography information for John Spellar more like this